| 靶点 | 产品货号 | 产品名称 |
|
RABV
|
GM-78316AB
|
Anti-RABV-G mIgG1 Antibody
|
|
CD79
|
GM-28857AB
|
Anti-H_CD79B hIgG1 Antibody(Iladatuzumab)
|
|
SARS-COV-2
|
GM-32019AB
|
Anti-ACE2 hIgG4 Antibody(3E8)
|
|
INSR
|
GM-51390AB
|
Anti-INSR hIgG1 Antibody(XPA.15.247.2.018)
|
|
INSR
|
GM-27376AB
|
Anti-H_INSR hIgG1 Antibody(Valanafusp)
|
|
STEAP1
|
GM-33026AB
|
Anti-H_STEAP1 hIgG1 Antibody(Vandortuzumab)
|
|
CD71(TFRC)
|
GM-30129AB
|
Anti-H_TFRC(CD71) hIgG1 Antibody(Pabinafusp)
|
|
LY6E
|
GM-31757AB
|
Anti-H_LY6E hIgG1 Antibody(Hu9B12v12)
|
|
SARS-CoV-2
|
GM-28192AB
|
Anti-SARS-CoV-2 hIgG1 Antibody（Imdevimab）
|
|
MELTF(CD228)
|
GM-38396AB
|
Anti-H_MELTF(CD228) hIgG1 Antibody(hL49 HALC)
|
|
AAV2
|
GM-71169AB
|
Anti-AAV2 mIgG2a Antibody
|
|
AAV2
|
GM-71168AB
|
Anti-AAV2 mIgG1 Antibody
|
| 靶点 | 产品货号 | 产品名称 |
|
RABV
|
GM-78316AB
|
Anti-RABV-G mIgG1 Antibody
|
|
CD79
|
GM-28857AB
|
Anti-H_CD79B hIgG1 Antibody(Iladatuzumab)
|
|
SARS-COV-2
|
GM-32019AB
|
Anti-ACE2 hIgG4 Antibody(3E8)
|
|
INSR
|
GM-51390AB
|
Anti-INSR hIgG1 Antibody(XPA.15.247.2.018)
|
|
INSR
|
GM-27376AB
|
Anti-H_INSR hIgG1 Antibody(Valanafusp)
|
|
STEAP1
|
GM-33026AB
|
Anti-H_STEAP1 hIgG1 Antibody(Vandortuzumab)
|
|
CD71(TFRC)
|
GM-30129AB
|
Anti-H_TFRC(CD71) hIgG1 Antibody(Pabinafusp)
|
|
LY6E
|
GM-31757AB
|
Anti-H_LY6E hIgG1 Antibody(Hu9B12v12)
|
|
SARS-CoV-2
|
GM-28192AB
|
Anti-SARS-CoV-2 hIgG1 Antibody（Imdevimab）
|
|
MELTF(CD228)
|
GM-38396AB
|
Anti-H_MELTF(CD228) hIgG1 Antibody(hL49 HALC)
|
|
AAV2
|
GM-71169AB
|
Anti-AAV2 mIgG2a Antibody
|
|
AAV2
|
GM-71168AB
|
Anti-AAV2 mIgG1 Antibody
|
